Abstract

Non-cystic fibrosis bronchiectasis (NCFB) has gained renewed interest, due to its increasing health-care burden. Annual mortality statistics in England and Wales showed that under 1,000 people die from bronchiectasis each year, and this number is increasing by 3% yearly. Unfortunately, there is a severe lack of well-powered, randomized controlled trials to guide clinicians how to manage NCFB effectively. Quality-of-life (QOL) measures in NCFB are an important aspect of clinical care that has not been studied well. Commonly used disease-specific questionnaires in children with NCFB are the St George’s Respiratory Questionnaire, Short Form-36, the Leicester Cough Questionnaire, and the Parent Cough-Specific Quality of Life questionnaire (PC-QOL). Of these, only the PC-QOL can be used in young children, as it is a parent-proxy questionnaire. We reviewed pediatric studies looking at QOL in children with NCFB and cystic fibrosis. All types of airway clearance techniques appear to be safe and have no significant benefit over each other. Number of exacerbations and hospitalizations correlated with QOL scores, while symptom subscales correlated with lung function, worse QOL, frequent antibiotic requirements, and duration of regular follow-up in only one study. There was a correlation between QOL and age of diagnosis in children with primary ciliary dyskinesia. Other studies have shown no relationship between QOL scores and etiology of NCFB as well as CT changes. As for treatments, oral azithromycin and yoga have demonstrated some improvement in QOL scores. In conclusion, more studies are required to accurately determine important factors contributing to QOL.

Highlights

  • Specialty section: This article was submitted to Pediatric Pulmonology, a section of the journal Frontiers in Pediatrics

  • There are only five pediatric studies that look at QOL in children with Non-cystic fibrosis bronchiectasis (NCFB)

  • Number of exacerbations and hospitalizations correlated with QOL scores in one study, while symptom subscales correlated with the following: lung function, worse QOL, frequent antibiotic requirements, and duration of regular follow-up

Read more

Summary

TOOLS USED TO ASSESS QOL

Use of disease-specific questionnaires instead of generic ones has been shown to be far superior in adult respiratory disease [6,7,8]. In a recent systematic review of QOL questionnaires in patients with bronchiectasis, there was strong correlation with subjective symptoms but a weak correlation with objective assessments such as FEV1, radiological scoring, and exercise capacity [9]. The Quality of Life-Bronchiectasis (QOL-B) questionnaire has been validated for use in adults with bronchiectasis. It has 37 items on 8 scales: symptoms, physical, role, emotional and social functioning, vitality, health perceptions, and treatment burden. It uses a 7-point Likert-type scale with a minimum important difference of 0.9 [16]. Since cough is an important symptom in NCFB, the PC-QOL is an excellent tool to assess the burden of disease in young children.

KNOWLEDGE GAPS
BURDEN OF DISEASE IN CHILDREN
Patients reported worse physical QOL
No correlation between scores with age or age at diagnosis
WHAT ARE THE KNOWLEDGE GAPS?
POSSIBLE TREATMENT DETERMINANTS OF QOL
Antibiotics other than Macrolides
Inhaled Steroids
CONCLUSION
Findings
Key Concepts
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call